Airway response to mannitol among healthy subjects
Open Access
- 16 May 2025
- journal article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (6)
Abstract
Background: Little is known how subject characteristics affect the airway responsiveness to mannitol, what is the upper limit of a normal response, and what is the reproducibility of the response among healthy subjects. Methods: Mannitol testing was performed in 125 healthy, nonsmoking subjects with an age range of 18–82 years and an almost equal male-to-female ratio. 25 of them repeated the test. The airway response to mannitol was expressed as the final percentage fall in forced expiratory volume in 1 s (FEV 1 ) after the final cumulative dose of mannitol (FFALL) and as response-to-dose ratio (RDR), calculated as FFALL divided by the final cumulative dose of mannitol. The upper limits of the normal response were calculated as mean+1.65× sd . Results: Neither age, gender, height, body mass index, atopy, nor baseline FEV 1 affected the responses statistically significantly. The mean± sd FFALL was 5.29±4.90% with an upper limit of 13.4%. The mean± sd RDR was 0.78±0.71% per 100 mg with an upper limit of 1.96% per 100 mg. In the repeated tests, the intraclass correlation coefficients were 0.46 and 0.35, respectively. Conclusion: The subject characteristics do not have a significant effect on the airway responsiveness to mannitol. Therefore, the same upper limits of a normal response can be used in all adult nonsmoking subjects. Among healthy subjects with very mild airway responsiveness to mannitol, FFALL and RDR are poorly reproducible.Keywords
Funding Information
- Kuopion Seudun Hengityssäätiö
- Foundation of the Finnish Anti-Tuberculosis Association
- North Savo Regional Fund of the Finnish Cultural Foundation
This publication has 40 references indexed in Scilit:
- The Cough Response to Inhaled Mannitol in Healthy SubjectsLung, 2024
- Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammationJournal of Allergy and Clinical Immunology, 2023
- Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypesJournal of Allergy and Clinical Immunology, 2023
- Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthmaJournal of Allergy and Clinical Immunology, 2022
- Mannitol triggers mast cell–dependent contractions of human small bronchi and prostacyclin bronchoprotectionJournal of Allergy and Clinical Immunology, 2019
- Airway Hyperresponsiveness to Mannitol in Obesity Before and After Bariatric SurgeryObesity Surgery, 2015
- Response–Dose Ratio is a Surrogate of Cumulative Provocative Dosage for Bronchial Provocation Tests in AsthmaLung, 2014
- Repeatability of bronchial responsiveness to mannitol dry powder in children with asthmaPediatric Pulmonology, 2003
- A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurementComputers in Biology and Medicine, 1990
- Daily Spirometric VariabilityArchives of internal medicine (1960), 1982